Jennifer M Binning

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersGlycobiologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2026
Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple Myeloma.

|Apr 03, 2026
Ancestral protein reconstruction reveals the mechanism of substrate specificity in FN3K-mediated deglycation.

Jenet K Matlack, Robert E Miner, Jameela Lokhandwala

|Aug 06, 2025
Ancestral protein reconstruction reveals the mechanism of substrate specificity in FN3K-mediated deglycation.

Jenet K Matlack, Robert E Miner, Jameela Lokhandwala

|Oct 28, 2024
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer.

Tracess B Smalley, Angelo Nicolaci, Kim C Tran

|Jul 06, 2022
Rethinking the immunotherapy numbers game.

Rebecca A Bekker, Mohammad U Zahid, Jennifer M Binning

|Jan 06, 2018
Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.

Jennifer M Binning, Amber M Smith, Judd F Hultquist

Pageof 1

Frequent Collaborators

1 joint publications

Charles S Craik

1 joint publications

Yifan Cheng

1 joint publications

John D Gross

1 joint publications

Rebecca A Bekker